Bridger Management, LLC (1)

Insider profile

Bridger Management, LLC (1)'s trades of Teva Pharmaceutical Industries Limited's stock


Loading...
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2026-09-18 2026-09-18 PrS Proposed sale
57,505
173.47
US$1,349,058
57,505 173.47 US$1,349,058
2025-12-12 2025-12-12 PrS Proposed sale
30,689
335.17
US$3,077,141
30,689 335.17 US$3,077,141
2025-11-26 2025-11-26 PrS Proposed sale
30,305
109.93
US$2,631,609
30,305 109.93 US$2,631,609
2025-11-06 2025-11-06 PrS Proposed sale
200,000
24.60
US$4,920,000
200,000 24.60 US$4,920,000
2025-09-12 2025-09-12 PrS Proposed sale
95,000
19.89
US$1,889,550
95,000 19.89 US$1,889,550
2024-12-20 2024-12-20 PrS Proposed sale
286,000
21.31
US$6,094,660
286,000 21.31 US$6,094,660
2024-06-18 2024-06-18 PrS Proposed sale
519,000
17.12
US$8,885,280
519,000 17.12 US$8,885,280